Toll-Like Receptor 4 Deficiency Increases Disease and Mortality after Mouse Hepatitis Virus Type 1 Infection of Susceptible C3H Mice
暂无分享,去创建一个
[1] S. Fukushi,et al. Mouse-Passaged Severe Acute Respiratory Syndrome-Associated Coronavirus Leads to Lethal Pulmonary Edema and Diffuse Alveolar Damage in Adult but Not Young Mice , 2008, The American Journal of Pathology.
[2] Arthur S Slutsky,et al. Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury , 2008, Cell.
[3] R. Baric,et al. Animal models and vaccines for SARS-CoV infection , 2007, Virus Research.
[4] Alan D. Roberts,et al. Aging and CD8+ T cell immunity to respiratory virus infections , 2007, Experimental Gerontology.
[5] A. Heinzmann,et al. TLR-4 and CD14 Polymorphisms in Respiratory Syncytial Virus Associated Disease , 2007, Disease markers.
[6] Ralph Baric,et al. A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice , 2007, PLoS pathogens.
[7] G. Downey,et al. MurineHepatitis Virus Strain 1 Produces a Clinically Relevant Model of Severe Acute Respiratory Syndrome in A/J Mice , 2006, Journal of Virology.
[8] S. Swain,et al. Why Aging T Cells Fail: Implications for Vaccination , 2006, Immunity.
[9] A. Oron,et al. Lipopolysaccharide hyporesponsiveness as a risk factor for intensive care unit hospitalization in infants with respiratory syncitial virus bronchiolitis , 2006, Clinical and experimental immunology.
[10] Jonathan H. Epstein,et al. Bats Are Natural Reservoirs of SARS-Like Coronaviruses , 2005, Science.
[11] C. Taube,et al. Strain‐specific differences in perivascular inflammation in lungs in two murine models of allergic airway inflammation , 2005, Clinical and experimental immunology.
[12] K. Subbarao,et al. Aged BALB/c Mice as a Model for Increased Severity of Severe Acute Respiratory Syndrome in Elderly Humans , 2005, Journal of Virology.
[13] Samson S. Y. Wong,et al. Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia , 2005, Journal of Virology.
[14] John Bechill,et al. Identification of Severe Acute Respiratory Syndrome Coronavirus Replicase Products and Characterization of Papain-Like Protease Activity , 2004, Journal of Virology.
[15] R. Crystal,et al. Resolution of Primary Severe Acute Respiratory Syndrome-Associated Coronavirus Infection Requires Stat1 , 2004, Journal of Virology.
[16] A. Gigliotti,et al. Inhaled diesel engine emissions reduce bacterial clearance and exacerbate lung disease to Pseudomonas aeruginosa infection in vivo. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[17] B. Murphy,et al. Mechanisms of Host Defense following Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) Pulmonary Infection of Mice , 2004, The Journal of Immunology.
[18] N. Amariglio,et al. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. , 2004, The Journal of infectious diseases.
[19] Michelle M. Packard,et al. Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice , 2004, Journal of Virology.
[20] B. Berkhout,et al. Identification of a new human coronavirus , 2004, Nature Medicine.
[21] J. Sung,et al. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS) , 2004, Journal of Clinical Pathology.
[22] J. Peiris,et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003 , 2003, The Lancet.
[23] Y. Guan,et al. Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage , 2003, Journal of Molecular Biology.
[24] P. Hawkey,et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. , 2003, Journal of medical microbiology.
[25] Xin Li,et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China , 2003, The Journal of pathology.
[26] W. Travis,et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore , 2003, Human Pathology.
[27] Christian Drosten,et al. Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.
[28] Obi L. Griffith,et al. The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.
[29] Yi Guan,et al. Lung pathology of fatal severe acute respiratory syndrome , 2003, The Lancet.
[30] J. A. Comer,et al. A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.
[31] K. Holmes,et al. SARS-associated coronavirus. , 2003, The New England journal of medicine.
[32] Malik Peiris,et al. Aetiology: Koch's postulates fulfilled for SARS virus , 2003, Nature.
[33] Peter Cameron,et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.
[34] K. Stöhr. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome , 2003, The Lancet.
[35] Arthur S Slutsky,et al. Identification of severe acute respiratory syndrome in Canada. , 2003, The New England journal of medicine.
[36] T. S. Moran,et al. Acute Changes in Lung Histopathology and Bronchoalveolar Lavage Parameters in Mice Exposed to the Choking Agent Gas Phosgene , 2002, Toxicologic pathology.
[37] P. Openshaw,et al. Inhibition of tumor necrosis factor reduces the severity of virus‐specific lung immunopathology , 2001, European journal of immunology.
[38] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[39] E. Gelfand,et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. , 1997, American journal of respiratory and critical care medicine.
[40] T. Gallagher,et al. Murine coronavirus membrane fusion is blocked by modification of thiols buried within the spike protein , 1996, Journal of virology.
[41] L. Weiner,et al. Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease☆ , 1987, Microbial Pathogenesis.
[42] L. Weiner,et al. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies , 1986, Journal of virology.
[43] L. Rorke,et al. Experimental demyelination produced by the A59 strain of mouse hepatitis virus , 1984, Neurology.
[44] L. Weiner,et al. Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. , 1982, The Journal of general virology.
[45] R. Knobler,et al. Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4 , 1982, Nature.
[46] D. Rosenstreich,et al. Characterization of a congenitally LPS-resistant, athymic mouse strain. , 1979, Journal of immunology.
[47] C. Andrewes,et al. Production of hepatitis in mice by the combined action of two filterable agents. , 1952, Lancet.
[48] J. Fleming,et al. Pathogenesis of mouse hepatitis virus-induced demyelination. , 1996, Journal of neurovirology.